Summit Therapeutics Inc. (SMMT) NASDAQ

15.94

+0.07(+0.44%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap12.83B
Enterprise Value12.73B
P/E Ratio-12.86
PEG Ratio0.56
Price/Sales Ratio0
Price/Book Ratio61.63
Enterprise/Revenue0
Enterprise/EBITDA-12.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-3.52
Return On Equity-3.11

Income Statement

Revenue0
Revenue/Share0
Gross Profit-15.01M
EBITDA-212.85M
Net Income-221.32M
Diluted EPS-0.31

Balance Sheet

Total Cash238.88M
Total Cash/Share0.32
Total Debt5.43M
Total Debt/Equity0.03
Current Ratio3.8
Book Value Per Share0.26

Price History

52-Week Change-27.94
52-Week High36.91
52-Week Low13.83
Moving Average 50 Days16.91
Moving Average 200 Days20.98

Statistics

Average Volume2.7M
Shares Outstanding744.44M
% Held by Institutions15.77

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A